3-iodobenzylguanidine has been researched along with Prodromal Characteristics in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Arafuka, S; Fujishiro, H; Iritani, S; Iwamoto, K; Miyata, S; Ogasawara, K; Ozaki, N; Torii, Y | 1 |
Berg, D; Postuma, RB | 1 |
1 review(s) available for 3-iodobenzylguanidine and Prodromal Characteristics
Article | Year |
---|---|
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders | 2019 |
1 other study(ies) available for 3-iodobenzylguanidine and Prodromal Characteristics
Article | Year |
---|---|
Temporal trajectories of proposed biomarkers in psychiatric-onset prodromal dementia with Lewy bodies: a case report.
Topics: 3-Iodobenzylguanidine; Biomarkers; Humans; Lewy Bodies; Lewy Body Disease; Prodromal Symptoms | 2023 |